Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Statin, antiplatelet prescriptions lag for PAD patients at risk of stroke

Heart patients with symptoms of peripheral artery disease (PAD) continue to see low rates of prescriptions for antiplatelets, statins and ACE inhibitors, despite those drugs’ potential to prevent against major events like stroke, according to research published Nov. 15 in Stroke.

November 16, 2018

Severe migraines could signal elevated risk for AFib, stroke

A decades-long study of patients who have migraines with visual aura has linked the painful headaches to an increased risk of experiencing atrial fibrillation and, to a lesser degree, stroke, researchers report in the online edition of Neurology.

November 15, 2018

Algorithm leans on patient-reported variables to predict mortality

A machine learning algorithm that predicts five-year mortality among patients with atherosclerotic cardiovascular disease (ASCVD) makes the case that patient responses to questionnaires can be just as informative in risk stratification as clinical characteristics and lab measurements.

November 12, 2018
snapchat-2480959_960_720.jpg

How Snapchat saved a stroke patient’s life with 12 minutes to spare

Social media app Snapchat has been credited with saving 39-year-old Darnisha Ladd’s life after a recorded video helped physicians diagnose the young stroke survivor, allowing them to administer life-saving medication with 12 minutes to spare, the Omaha World-Herald has reported.

November 9, 2018

DOACs cut dementia risk in AFib patients more than warfarin

For patients with nonvalvular atrial fibrillation (AFib), taking a direct oral anticoagulant (DOAC) instead of warfarin may cut the risk of dementia by 15 to 20 percent, according to a large database study published Nov. 2 in the Journal of the American Heart Association.

November 8, 2018

New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD

Medtronic data presented today reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal arteries.

November 6, 2018

The Eluvia drug-eluting stent continues to demonstrate positive outcomes in long lesion IMPERIAL sub-study

Boston Scientific announced clinical outcomes from the IMPERIAL Long Lesion Sub-study demonstrating that the Eluvia Drug-Eluting Vascular Stent System is safe and effective in treating patients with long, complex, calcified lesions within the superficial femoral and proximal popliteal arteries.

November 6, 2018
fda-logo-large_900x550.jpg

FDA issues Class I recall for warfarin test strips after patient strokes

The FDA has announced a Class I recall for 1.1 million packages of CoaguChek XS PT test strips used with point-of-care or in-home devices to adjust warfarin dosing.

November 5, 2018

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup